Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Apo-Paroxetine 20mg Tablet

Approval Number

SIN13485P

Drug Name

Apo-Paroxetine 20mg Tablet

Product Name

Apo-Paroxetine 20mg Tablet

Approval Date

July 10, 2008

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

N06AB05

ATC Item Name

paroxetine

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

Apotex Inc

Active Ingredients

Ingredient Name

Paroxetine Hydrochloride 22.2mg eqv to Paroxetine

Strength

20.0mg

Drug MonographParoxetine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

Apo-Paroxetine 20mg Tablet - HSA Approval | MedPath